XLEquine and the Animal Health Trust (AHT) have launched Plan, Prevent, Protect, billed as the UK's first equine biosecurity booklet for horse owners and yard managers to work through with their veterinary surgeon, to minimise disease risk on yards and maintain the health and welfare of the horses in their care.
Mark Tabachnik MRCVS, of XLEquine member practice Wright & Morten Veterinary Surgeons said: "For many yard and horse owners, biosecurity is just not on their radar. It only becomes important after they have had an outbreak! Strangles in particular can have devastating effects which impact not only on horse welfare, but the disruption and paralysis of animal movement has significant consequences with relationships on the yard, not to mention the financial costs in some cases.
"We wanted to develop a practical guide that pre-empts these issues by helping owners to set in place simple and in many cases common sense, plans and procedures to prevent a disease outbreak, along with practical steps should the worst happen, and an outbreak occurs.
"Our veterinary farm colleagues and the medical profession are well ahead in terms of biosecurity measures. It's about changing people's mind-sets. For example the NHS "Catch it Bin it Kill it" campaign has been highly successful in adapting our thoughts and actions towards disease spread, and consequently many of us are more aware of the importance of good biosecurity in one way or another."
Dr Richard Newton, Head of Epidemiology and Disease Surveillance at the AHT was also involved in the development of the booklet. He said: "I hope that this will encourage all equine practices to raise their game, it is so important for the whole equine community."
The booklet is available to all equine clients of XLEquine member practices, or it is available to view at http://www.xlequine.co.uk/content/plan-prevent-protect
The Westpoint Veterinary Group and Eville & Jones, a veterinary control provider, have joined forces to form Xperior Farm Health, which will bid for appointment as a Delivery Partner for bovine TB and other farm animal disease testing under AHVLA's Veterinary Delivery Partnership Programme.
The Delivery Partnership Programme, under which the AHVLA will cease to contract OVs directly and instead procure disease testing services from around ten Delivery Partners, is expected to roll out in the summer.
Eville & Jones is an experienced service provider in inspection and testing services in the fields of animal health, public health and animal welfare. The company employs more than 450 veterinary staff nationwide and already provides fully managed Official Veterinarian (OV) services to UK Competent Authorities.
Westpoint Veterinary Group is a specialist, farm-animal-only veterinary practice operating from 17 sites countrywide to provide farmers with specialist and locally based services. It is the largest veterinary group in the UK specialising in production animals, employing more than 50 veterinary surgeons.
Veterinary Director Phil Elkins MRCVS says the resources and experience of the two parent companies in both farmer-facing and back office dimensions make Xperior Farm Health well equipped to fulfil a Delivery Partner service expected by AHVLA. He said: "Our ambition is to provide an exemplary standard of accurate and trustworthy on-farm animal health testing services, where possible using subcontracted practices. If appointed, of course, these will be farmer friendly, provide an ongoing source of work and revenue to subcontractor Official Veterinarians, and represent excellent value for money to the taxpayer."
The President of the British Veterinary Association has written to the Badger Trust to clarify the BVA position on the pilot badger culls in England, stating that it will not be supporting the Trust's application for a judicial review.
The BVA Council agreed a position on the continuation of controlled shooting in the pilot areas on 16 April. The position states that the BVA could only support further culling using controlled shooting in the pilot areas if steps are taken to improve both its effectiveness and humaneness and if there is robust monitoring and collation of results and independent analysis and auditing by a non-governmental body. It also states that the BVA supports the Independent Expert Panel's (IEP) recommendations for improving effectiveness and humaneness and urges Defra to implement all the IEP's recommendations fully.
The BVA says that since 16 April, it has been in dialogue with Defra to seek assurances that these issues will be addressed, and those discussions are ongoing. It will not be taking a further position on the pilot culls until BVA Council has had the opportunity to consider Defra's plans in full, when they are made available.
In a press release dated 20th May, The Badger Trust CEO Dominic Dyer said: "It is not acceptable for the DEFRA Secretary of State to now push aside the concerns of both the Independent Expert Panel and the British Veterinary Association, by moving ahead with a further badger cull in Gloucestershire and Somerset this summer without any independent monitoring in place."
The BVA says it is concerned that this misrepresents its position, and has led to some media reports suggesting that the BVA has withdrawn its support for badger culling as part of the overall strategy to eradicate bovine TB. It has not. The BVA says it continues to believe that the TB eradication strategy for England will only be successful if we are able to use all of the available tools, including targeted, humane badger culling.
The RCVS has released the results of a survey it conducted which has found that the vast majority of recent graduates from UK veterinary schools consider extra-mural studies (EMS) to be an essential component of the veterinary degree.
The survey was launched earlier this year in order to help the RCVS build up a picture of how EMS placements are currently working and whether graduates felt that they had gained knowledge and experience from placements that they could not have learnt from their core studies. Some 287 veterinary graduates from 2012 and 2013 participated in the survey, the overwhelming majority of whom (95.6%) agreed that EMS was essential.
Furthermore, the majority of the recent graduates said that they had found EMS placements to be beneficial in terms of the variety of clinical skills, professional skills and working practices they encountered. The only area in which a large number of graduates (42.9%) said that they did not find EMS placements useful was in gaining experience of out-of-hours and weekend work.
Despite the overall positive results, however, a number of concerns about EMS were raised. Issues included variable quality of placements; significant numbers of respondents feeling they were not able to gain as much 'hands-on' experience from placements as they would like; costs of accommodation and travel; and a lack of farm/mixed animal practices for placements.
Other key findings included the fact that the vast majority of veterinary students identified and booked their own placements at EMS practices and that their placements were at the type of practice they were looking for.
Christine Warman, RCVS Head of Education, said: "We launched this survey as an information-gathering exercise to see how EMS placements are currently working, following our last review of EMS in 2009 - and the results have certainly been very interesting.
"What is clear is that the current system is working well and that there is no need for an immediate review or urgent action. Most graduates found the experience gained on placements useful for their studies and find that EMS sets them up well for their first job in practice.
"However, there are a number of issues that we will keep a watching brief over and we plan to repeat the survey every two years in order to monitor these."
The full results of the survey are available to view at www.rcvs.org.uk/emssurvey2014. Detailed guidance on EMS placements for students, university staff and EMS practices is also available at www.rcvs.org.uk/ems.
Any queries about EMS can also be directed to the RCVS Education Department on education@rcvs.org.uk or 020 7202 0704.
The RSPB has reported the results of two studies which revealed that a greater diversity of birds of prey, including some eagles, are killed eating carrion contaminated with diclofenac.
The RSPB says that these findings strengthen the case of banning the use of veterinary diclofenac in livestock across Europe, including Spain and Italy where the drug has already been approved.
In the first paper1, published in the journal Bird Conservation International, scientists present results of tests carried out on two steppe eagles found dead at a cattle carcass dump in Rajasthan, India. Both birds had diclofenac residue in their tissues and exhibited the same clinical signs of kidney failure as seen in Gyps vultures experimentally given diclofenac.
Steppe eagles are closely related to the golden eagles found in the UK, the vulnerable Spanish imperial eagle and other globally vulnerable or declining Eurasian eagles. Scientists now fear that all species in this genus, known as Aquila, are susceptible to diclofenac. With fourteen species of Aquila eagle distributed across Asia, Africa, Australia, Europe and North America, this means that diclofenac poisoning should now be considered largely a global problem.
Dr Toby Galligan, RSPB conservation scientist and one of the authors of the paper, said: "We have known for some time that diclofenac is toxic to Gyps vultures, including the Eurasian griffon vulture, but we now know it is toxic to an Aquila eagle too. This suggests that the drug is fatal to a greater number of birds of prey in Asia, Europe and around the world. We had suspected as much from observed declines in non-Gyps vultures in Asia, but this study confirms our worst fears."
In another paper2, published in Bird Conservation International, Dr Galligan led an examination of recent population trends in Egyptian and red-headed vultures in India. That study shows population declines of similar timing and scale as the declines observed in Gyps vultures, providing indirect evidence that these species have been impacted by diclofenac as well.
After years of campaigning by conservationists, the governments of Bangladesh, India, Nepal, and Pakistan banned veterinary formulations of diclofenac between 2006 and 2010. Recently, experts have recorded a slowing of Gyps vulture declines as a result of the bans. However, formulations of diclofenac intended for use in humans are still widely available and illegally used to treat livestock, the carcasses of which are the main food source for vultures in South Asia. It was announced in March that veterinary diclofenac had been authorised for manufacture and use in Italy and Spain and had been distributed to other European countries. Since then, a coalition of organisations including the Vulture Conservation Foundation, the RSPB and BirdLife International have been campaigning for this decision to be reversed.
Dr Galligan continued: "In light of recent developments in Europe, our findings take on an even more worrying meaning. All of Europe's charismatic Aquila eagles, like the Spanish imperial eagle and, closer to home, the golden eagle, are opportunistic scavengers and therefore could be at risk of diclofenac poisoning. As we have seen in South Asia, wherever free-ranging livestock are treated with diclofenac, population declines in vultures and eagles can occur. The European Commission needs to recognise this problem and impose a continent-wide ban on veterinary diclofenac before it can impact on our birds."
Last week, the Veterinary Medicines Directorate (VMD) announced measures against the drug.
In a statement the VMD said: "The UK's Veterinary Medicines Directorate is taking the issue of diclofenac's risks to vulture populations seriously. As a precautionary measure the VMD will not approve any requests from vets to import products containing diclofenac. Furthermore, the VMD has agreed not to issue any export certificates which name diclofenac-containing products in the list of products to be exported."
Sacha Cleminson, Head of International Biodiversity Policy at the RSPB, said: "The announcement from the Veterinary Medicines Directorate is a welcome signal to Europe that the UK is taking the issue seriously. This new evidence underlines the need for a ban across Europe, and ultimately beyond."
References
Have population declines in Egyptian Vulture and Red-headed Vulture in India slowed since the 2006 ban on veterinary diclofenac? Toby H. Galligan et al. Bird Conservation International Online. 1st April 2014.
Elanco Companion Animal Health has launched a competition to encourage veterinary professionals to showcase the company's new range of practice support materials for the company's parasiticides, Comfortis and Trifexin.
To enter the competition, you'll first need to order the support materials, which include: waiting room posters, client leaflets and a waiting room leaflet dispenser, modular window hangers, social media artwork and display kits which consist of 19 die-cut colour pieces for waiting room displays. Entry / order forms are available here.
Then create your display and email a digital photograph of it to Elanco before the 29th August 2014.
Matthew Rowe, Senior Brand Manager at Elanco said: "We're asking veterinary practices to use their creativity and imagination when putting up their parasite control displays. Last year's winner, the Animal Health Centre in Torquay, even composed their own song, so the more creative the better!"
The overall winner will win a team celebration worth £1000, and there are £250 Amazon vouchers for 11 regional winners.
For further information contact your local Elanco Companion Animal Health key account manager or email elancocahuk@elanco.com
The Alliance to Save Our Antibiotics is urging the Prime Minister to make the announcement on antimicrobial resistance he promised the House of Commons during Prime Minister's Questions on Wednesday 7th May 2014.
In a reply to a question from Zac Goldsmith MP, David Cameron acknowledged that the problem of antibiotic resistance could have 'unbelievably bad consequences' leading to quite minor ailments not being properly treatable by antibiotics. The Alliance is urging the government to take urgent action to reduce antibiotic use in both medicine and farming.
The issue was further highlighted at this year's World Health Assembly (WHA) Conference when attendees confirmed that a catastrophic post-antibiotic age - in which minor, common infections could again become killers - is a real possibility unless urgent action is taken.
At the conference, the Netherlands' Minister of Health, Edith Schippers said: "People are getting seriously ill and are dying as a result of skin infections and diarrhoea. Common surgeries like knee replacement will become potential killers because of secondary infections that are untreatable. This is a global problem on a par with, if not more serious than, nuclear security, international terrorism and climate change."'
In a letter to David Cameron on 13th May 2014, the Alliance to Save Our Antibiotics said: "It simply does not make sense to be feeding nearly half of all the antibiotics used in this country to farm animals, just so that they can be kept in high numbers indoors, often in conditions which carry with them the risk of high levels of disease."
The Alliance says the measures the Prime Minister is due to announce must include the urgent phase-out of the routine preventative use of antibiotics in farming.
Alison Craig, Campaign Manager for the Alliance to Save Our Antibiotics said: "Our near European neighbour the Netherlands has phased out routine preventative use of antibiotics in farming by government taking strong and decisive action and industry taking voluntary measures - so why can't we do the same in the UK?"
In 2007 the Netherlands was one of the world's heaviest users of antibiotics in food animals. In 2009 the government decided to decrease farm use of antibiotics by 50%. This was achieved by 2013.
Alison continued: "It is alarming that, in this country, we don't even yet know how many people are already dying due to antimicrobial resistance. By contrast, in the Netherlands they know that there are 2 million hospitalisations per year due to resistance.
"If the Prime Minister knows that there will be 'unbelievably bad consequences' for families, why is his government being so slow about getting a grip on the problem?"
The PDSA has announced the start of its annual pet slimming competition, and revealed the 17 competitors who will be fighting to win the title of Pet Fit Club Slimmer Of The Year.
The competition is run to highlight the high level of pet obesity in the UK. According to the charity, around a third of all dogs (2.5M) and a quarter of all cats (2M) are estimated to be overweight.
PDSA research has shown that 87% of owners give their pets treats, despite the fact that 91% realise the resulting obesity can reduce their pet's lifespan. The PDSA's PAW Report, produced in conjunction with YouGov, discovered that a wide range of inappropriate treats are being fed to pets, including fast food, leftovers, crisps, biscuits, chocolate and chips.
Elaine Pendlebury, PDSA Senior Veterinary Surgeon, said: "Obesity is one of the biggest welfare issues affecting pets in the UK today. Sadly, it also means millions of pets are at risk from potentially life-threatening health problems related to obesity."
For more information about the finalists, please visit www.pdsa.org.uk/petfitclub
Vétoquinol has announced that Zylkène, a complementary feed used to help pets cope with unpredictable situations, is now available in a 20 capsule pack.
The new packs have been designed to have more 'stand out appeal' on the shelves. Veterinary practices will now be able to display the new packs in waiting rooms and reception areas in a custom-made display unit to generate interest from pet owners and increase revenue for the practice.
Krystyna Joyce, Product Manager at Vétoquinol, said: "This has a huge benefit for the vet practice. As well as increased revenue, pet owners are much more likely to initiate a discussion about behaviour if they can see that there is a product to help their pet adjust to unusual circumstances or environmental changes."
Krystyna added: "With a number of behaviour products on the market, it can be confusing for pet owners to know which ones can be used when. We want to make it easier for pet owners: now when they come to their vets, they can see Zylkène, know what it's for, understand which strength will be right for their pet and pick it up."
As well as increasing product awareness, the packs will work alongside Vétoquinol's ongoing series of pet owner guides which offer advice on how best to help an animal deal with an unusual situation or life change.
Zylkène retail packs are available now from any veterinary wholesaler.
Vygon Vet has launched two new 'procedure packs' containing disposable essentials for unblocking a tomcat or performing a spay or minor surgery.
The KatKath Urinary Catheter Insertion Pack contains a catheter, a drape towel, polypropylene suture, lubricating gel, a Luer-slip syringe and a clear tray. The complete set costs £10.99.
Vygon Vet General Manager Chris Kenyon, said: "Not only does our KatKath pack ensure everything that's needed is in one place and sterile, it can also save vets up to 50% compared with prices if they buy similar products separately. It's a win-win situation."
The Spay Tray and Minor Operations Set (pictured right) includes a selection of forceps, a Mayo Hagar needle holder, a scalpel, a pair of dissecting scissors, a hand towel, drapes, a tray and five radiopaque swabs.
Chris said: "Our Spay Tray and Minor Ops Sets are produced to the highest standards using top quality materials. Having the required items in one pack eradicates the need to go through the expensive process of washing, re-packing and re-sterilisation, and from an admin point of view invoicing is easy with one single code covering all the different pack parts."
The Spay Tray and Minor Ops Sets are available for an introductory price of £12.50 for a limited period.
In the blurb, Vygon Vet says the benefits of its procedure packs include:
The company is also offering a retrieval service through which the instruments from up to ten packs can be disposed for £14.50.
For more information, visit www.vygonvet.co.uk, telephone: 01793 748900 or visit Vygon Vet at the forthcoming BSAVA Scottish Congress (29-31st August at the Edinburgh Conference Centre).
The Royal Veterinary College and the Animal Health Trust are trying to recruit 3000 horse and pony owners to take part in 'CARE about laminitis', a web-based research project that aims to reduce the threat caused by laminitis.
The four-year study, which is being funded by World Horse Welfare, is being conducted by PhD student, Danica (Dee) Pollard, based at the AHT. The main aims of the study are to:
Currently the veterinary-reported frequency of laminitis in Britain, estimated between 2009 and 2011, shows that active episodes of veterinary-diagnosed laminitis occurred in nearly 1 in 200 horses/ponies registered with veterinary practices, and accounted for nearly 1 in 200 equine visits. Dee said: "However an overall lack of studies into the frequency of laminitis leaves little to compare these estimates with."
If you'd like to take part in the study, or invite clients to do so, visit: www.careaboutlaminitis.org.uk or email danica.pollard@aht.org.uk.
Ceva Animal Health has announced the addition of a new CPD module to its Cardio Academy, covering the clinical significance of heart murmurs in cats.
Hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College, the online seminar provides guidance in deciding which heart murmurs are significant and working out which are more likely to develop complications, such as congestive heart failure or aortic thromboembolism.
According to the company, up to 40% of cats will have heart murmur at some point in their life, but are often clinically normal at presentation. To make things more confusing, says Ceva, 50% of cats with congestive heart failure do not have a heart murmur at all.
The module lasts for 20 minutes and, after viewing, delegates receive a CPD certificate by answering questions relating to the session.
To access this module, and 20 hours of online cardiology CPD, visit www.cardioacademy.cevalearn.com.
Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.
Dechra says it expects Osphos to change the way chronic lameness caused by navicular syndrome is tackled by equine vets.
According to the company, clinical trials of Osphos showed 74.7% of horses experienced improvement by at least one lameness grade at 56 days post treatment.
Dechra brand manager Emma Jennings said: "Osphos intramuscular injection contains the bisphosphonate clodronic acid which inhibits resorption in the navicular bone by binding to hydroxyapatite crystals and by direct cellular effects on osteoclasts.
"We are delighted with the results of the trials, which proved that Osphos is effective at 6 months post-treatment. We're looking forward to being able to support equine vets, vet nurses and practices by providing an intramuscular Clodronic acid injection for horses."
Dechra also says studies showed that mild transient colic was seen following just 1.6 per cent of treatments.
Osphos 60 mg/ml solution for injection for horses is available from September 2014.
The veterinary buying groups VetShare and London Vet Forum (LVF) have announced that they have merged to become the VetShare Buying Group.
VetShare Buying Group says that merger will ensure it has the resources and capabilities to compete in an industry that is increasingly made up of larger merged animal health suppliers.
The venture was prompted by a decision by London Vet Forum to offer itself up for a merger or sale with the aim of attracting better discounts for its members. It then interviewed a shortlist of candidates and says VetShare come out on top principally for its clarity and competitive discounts negotiated with the manufacturers.
In addition, VetShare and LVF shared some ways of working - members handle their own wholesaler invoice with the wholesaler-practice relationship remaining intact, allowing discounts to be rebated as a separate transaction. This means that members can continue to do business as before, while also benefiting from being part of the new, larger buying group.
Vet Ruth Gray, VetShare Director, said: "We are very pleased to have been chosen by the LVF directors to take their members into the future. We are the only major buying group without reps on the road and yet are now perhaps the largest buying group in the UK. We started VetShare initially to help our own practice achieve better discounts with the assumption that if we set up the perfect model for us then it would probably also be perfect for others. In hindsight, I think our assumption was right and this merger will mean even better discounts with new and exciting opportunities for existing members of both groups".
For more information on membership and the merged group, visit www.vetshare.co.uk or call Ruth on 0800 7566636.
Ceva Animal Health, manufacturer of Adaptil and Feliway, has launched a competition in which the practices that build the top ten dog dens in their client waiting rooms will win a luxury hamper worth £50.
The competition is designed to encourage practices to show clients how they can build a dog den to calm their dog during the fireworks season
To enter the competition, you need to post a picture of your waiting room dog den on the Adaptil Facebook page in October: https://www.facebook.com/pages/Adaptil/109397602429388?fref=ts.
Ceva also has a range of marketing materials for veterinary practices to use in the competition, including a hanging mobile, cut-outs, wobblers, posters and a leaflet and leaflet holder.
For additional hints and tips, a short film will also be available on the Adaptil website: www.adaptil.co.uk in due course. The footage includes information on preparing a den for a dog to hide in while the fireworks are going off.
For further information, contact your local Ceva territory manager or ,telephone 01494 781510.
The Veterinary Benevolent Fund (VBF) has announced the retirement of its President Dr. Lydia Brown, who had served the maximum of nine years as a trustee and member of the VBF Board.
Lydia became a director of the VBF following the merger of the Fund with the Vet Helpline (VHL) and the Veterinary Surgeons' Health Support Programme (VSHSP) in January 2005.
A past-president of the Royal College of Veterinary Surgeons (RCVS) and former chairman of the RCVS Trust, Lydia was a driving force behind the establishment of the VSHSP in 1999. This support programme was developed in response to the genuine need for a confidential service to treat veterinary surgeons with a wide variety of addictive conditions. Since then she has been involved in the expansion of the Helpline service from a telephone service to an increasingly-widely used email service.
The charity says that it is as a result of Lydia's thoroughness, sympathy and understanding, that very many veterinary surgeons and veterinary nurses have been helped to recover from many forms of addictive conditions and health problems.
Virbac has announced that it is running Canine Prostate Awareness Month (CPAM) in November, or 'Movember' as it's called by those fundraising for male prostate disease and testicular cancer.
With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)1, the aim of the initiative is to highlight the prevalence of the disease and to encourage practices and owners to check for and seek treatment for it.
As part of Canine Prostate Awareness Month, Virbac is providing participating practices with promotional materials including owner educational and display materials, postcards, an email/text message service, a template press release for local media and free branded slip leads for owners who get their dog checked during the promotion.
Sarah Walker BVM&S CertAVP MRCVS, Product Manager (Companion Animal), at Virbac, said: "CPAM aims to remind owners that men are not the only ones to suffer from prostate disorders. It's a well-supported initiative and, running it at a time when the media spotlight is already on the dangers of prostate cancer in men, means we can spread the message that owners should also be monitoring dogs for signs of prostate disease."
In the run up to the campaign, the company is highlighting OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, which is available from three UK diagnostic laboratories. Virbac says it is a cost-effective, precise and reliable alternative to rectal palpation. In addition, Virbac makes Ypozane, a tablet treatment for BPH, which it claims is effective within one week and last for six months.
Sarah added: "The problem with BPH is that the majority of dogs suffer in silence. It is a painful condition that too often goes unnoticed until it reaches an advanced stage, where the owner notices blood in the urine or painful urination.
"We're providing practices with all the materials they need to promote the campaign locally and hope those involved will find it effective in terms of bringing clients into the practice for advice on BPH. We've also organised coverage in national dog magazines to drive clients to practices."
For further information on CPAM, email cpam@virbac.co.uk; contact your Virbac Territory Manager or call the company direct on 01359 243243.
Reference
The National Office of Animal Health (NOAH) and the International Federation for Animal Health Europe (IFAH) have welcomed the European Commission's publication of proposals for revised legislation concerning veterinary medicines and medicated feed earlier today.
The EC says the proposals are designed to increase the availability of veterinary medicines, reduce administrative burden, stimulate competitiveness and innovation, improve the functioning of the internal market and address the issue of antimicrobial resistance.
NOAH says that currently, the manufacturers of veterinary medicines struggle with a regulatory system with some serious flaws, including:
NOAH chief executive Phil Sketchley said: "NOAH will be looking at the detail of the texts in the coming days and weeks, and reviewing their potential impact. We look forward to working with the VMD, who have called stakeholder workshops to examine the texts. We will also be supporting our European federation IFAH-Europe as they work determinedly with the European institutions over the coming years to support the Commission's vision for a more efficient regulatory system for veterinary medicines in Europe.
"We believe the value our industry brings to society is very high, despite being quite a small sector. For example, veterinary medicines benefit public health by preventing zoonotic disease and supporting food security.
"With synergies with our own UK Government's commitment to reduce unnecessary red tape, which is a key theme for DEFRA, the animal health industry in Europe needs greater efficiency to cut the red tape for our industry. We look forward to a streamlined registration process which delivers a single European marketing authorisation for all veterinary medicines.
"We will also be considering if the text has any particular implications for the UK animal health market and access to medicines for our animals."
NOAH says it also welcomes the revised medicated feed legislation. Phil Sketchley said: "NOAH believes this is an important route for administering prescription medicines to animals. We will work to help ensure the legislation is capable of maintaining and strengthening this route."
The British Equine Veterinary Association has published the results of a survey it commissioned which found that horse vets in the UK are probably at greater risk of injury than any other civilian profession, including the prison service.
For the study, which was conducted by the Institute of Health and Wellbeing and the School of Veterinary Medicine at the University of Glasgow, 620 equine vets completed a work-related injuries questionnaire. The results of the study indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
If the 620 respondents were representative of the rest of the profession, the injuries they reported would equate to 26,452 per 100,000 equine vets in employment per year. That compares with 10,760 for people working in the prison service, 8,700 for policemen below the rank of sergeant, 6,980 for welders, metal formers and related trades, and 4,760 for construction workers.
Participants were asked to describe their worst-ever injury. Most were described as bruising, fracture and laceration, with the most common site of injury being the leg (29%), followed by the head (23%). The main cause of injury was a kick with a hind limb (49%), followed by strike with a fore limb (11%), followed by crush injury (5%). Nearly a quarter of these reported injuries required hospital admission and notably, 7% resulted in loss of consciousness. The most common reason for the examination during which the injury occurred was foot lameness, followed by dental and female reproductive.
BEVA Past-President Keith Chandler said: “We were shocked to discover the extent of the injuries sustained. Of greatest concern is the number of vets who suffered head injuries and unconsciousness. These injuries appeared to be more common when certain procedures were being performed, such as endoscopy of the upper respiratory tract, when vets are often only partly sighted while using examination equipment, or during wound management and bandage-changes, where vets are often crouched-down for long periods, next to the patient.”
38% of the ‘worst’ injuries occurred when the vet was working with a ‘pleasure’ horse and most frequently (48% of all responses) the horse handler was the owner or the client at the time of the injury. Whilst the number of laypersons or handlers injured at the same time was low, Tim Parkin, vet and lead researcher, pointed out: “This work should act as a wake up call to all involved in the training, employment and engagement of equine vets. The risks associated with handling and working with horses should be the primary consideration for equine vets and horses owners alike, every time a horse is examined or treated. In addition, the experience of the horse handler should be considered when undertaking riskier procedures.”
David Mountford, Chief Executive of BEVA said: “The results are very concerning and justify a careful prospective scientific quantification of the risks. In the short term, knowledge of these risks allows us to better inform all vets who work with horses. In turn vets will be able to inform horse owners, horse-keepers and trainers of the risks, and this may provide justification for having trained assistance on-hand or the more extensive use of sedative drugs in practice, potentially reducing the risk of injury.
"The British Equine Veterinary Association will now look to work with the Health and Safety Executive, Veterinary Schools, large employers of vets in the UK and our members to help develop policies to mitigate the risk of serious injury for vets working with horses.”
Photograph courtesy Towcester Veterinary Centre
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, has been appointed as the new President of the British Equine Veterinary Association (BEVA) for 2014/15.
Andrew took over the role from Paul Jepson at the end of BEVA Congress last week. Mark Bowen, Associate Professor of Veterinary Internal Medicine at The University of Nottingham School of Veterinary Medicine and Science, becomes President Elect.Andrew said: "It is a privilege and an honour to take up the presidential reins for the next 12 months. It is unrealistic to expect to "change the world" in such a short time frame so the plan is to target certain areas, such as progressing New Safer Horse Rescue courses, strengthening BEVA's relationship with the BHA and moving forward with the regulation of Musculoskeletal Paraprofessionals. Not least it is a priority this year to make sure we keep aspiring vets realistically informed about future employment in our profession given the proliferation of undergraduate places available at UK and English speaking mainland European vet schools."
For further information visit www.beva.org.uk.
Ceva Animal Health has launched a new initiative to help young vets attend a variety of educational opportunities to further their knowledge of cattle reproduction.
The reprodAction Young Vet Initiative was introduced this month and three young vets have already taken part in the scheme.
The new initiative is open to recently qualified vets who are keen to improve their knowledge of cattle reproduction and who work for practices that are interested in growing their business by improving cattle reproduction on farms. The scheme includes Ceva-sponsored cattle fertility courses and dissertation programmes.
Emily Denton from Shropshire Farm Vets (pictured right), Annelyse Desbois From Meadows Farm Vets and Alun Beckett from Larkmead Veterinary Group were chosen to attend a CPD day 'A Practical Approach to the Non-Pregnant Cow', organised by Nottingham University.
Carol Atkinson, Ceva's reprodAction range marketing manager, said: "The purpose of this project is to give new graduates working in practice the opportunity to participate in quality CPD. The aim is to help them build their expertise and enthusiasm for cattle reproduction work via practical sponsorship."
Emily Denton has been an intern at Shropshire Farm Vets for the past year. She was chosen for the initiative having recently completed the XL vets farm new graduate programme. She said: "It was an exciting opportunity to build on the skills I have developed in practice and to discuss cases with my peers and with other, more experienced clinicians. The course was excellent - my take home message was that as cow genetics change it affects their cycle. Our ability to manipulate this is dependent on having a good, accurate knowledge of the physiological changes taking place."
For more information about taking part in the reprodAction Young Vet Initiative, contact your Ceva Territory Manager.
The Waltham Centre for Pet Nutrition has announced new research - published in BMC Vet Research1 - which examined the progression of periodontal disease in miniature schnauzers and found that without effective and frequent oral care, dental disease developed rapidly and advanced even more quickly with age.
Over the course of 60 weeks, full mouth examinations were conducted on 52 miniature schnauzers ranging in age between 1.3 and 6.9 years. Prior to the study, each dog had a regular oral care routine that included tooth brushing. This was suspended a week before the initial dental assessment. Of the 2,155 teeth examined, all entered the study with some level of gingivitis, while only 23 teeth entered with periodontitis.
Every 6 weeks, levels of gingivitis and periodontitis were assessed around the whole surface of each individual tooth by measuring periodontal probing depth, gingival recession and furcation exposure. Teeth were assessed for the level of gingivitis (scored between 0 and 4) and periodontitis (PD1 - up to 25% attachment loss and PD2 - between 25 to 50% attachment loss). Teeth from only one dog in the study did not progress to periodontitis.
Researchers found that, without regular oral care, the majority of dogs developed the early stages of periodontal disease within six months and dogs above the age of four developed periodontal disease even faster. The degree to which periodontal disease progressed varied based on the type of tooth and location on the tooth.
Furthermore, the study showed that periodontitis developed regardless of the visible signs of gingivitis, which had previously been believed to reliably precede it. Therefore while a visual inspection may be sufficient to detect a disease like gingivitis, it is not useful in detecting the onset of periodontitis and may not reveal the areas at greatest risk for dental disease.
Dr Stephen Harris, leader of the oral care team at WALTHAM, part of Mars Petcare said: "We all want to do the very best for our pets' health, and the study showed us that there's more than meets the eye when it comes to small dogs' oral health.
"Some pet owners "lift-the-lip" and look at a dog's gums to get a sense of its oral health, but this research shows they could be missing important early signs of dental disease. The findings should encourage all dog owners to establish an oral care routine that consists of regular tooth brushing supplemented with dental chews and veterinary checks. It's important for all dogs, but we know that small dogs like miniature schnauzers are at an even higher risk of developing severe dental problems."
Reference:
Merial Animal Health has launched Allevinix, a flunixin-based non-steroidal anti-inflammatory (NSAID) pain killer for cattle, pigs and horses.
Victoria Hudson, Product Manager for Merial Animal Health said: "We have positioned Allevinix as the flexible flunixin that meets your needs, because it offers flexibility in every area.
"It is the only flunixin licensed for both intramuscular and intravenous administration in cattle and we know that this will be very welcome for many vets and farmers. It can be used across cattle, pigs and horses, and it is the first injectable NSAID to come in a durable, non-breakable bottle."
Merial says Allevinix is fast-acting against inflammation, pain and fever, reaching peak plasma levels approximately 30 minutes after injection. It is available in 100ml and 250ml PET bottles and joins Ketofen as part of a range of NSAIDs available from Merial. It can also be used in conjunction with Merial's antimicrobial treatment for calf pneumonia - Zactran.
Victoria added: "We believe that vets will find this is a useful and innovative addition to the range of options that they have in terms of NSAIDs. Allevinix has a number of advantages over other flunixin products currently on the market."
Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.
Equine Gastric Ulceration Syndrome (EGUS) is a serious and common condition affecting horses and foals.2,3 Approximately 90% of racehorses, 60% of performance horses, 37% of leisure horses and 50% of foals have been shown to be affected.2,4,5 The condition is associated with injury to the mucosa of the oesophagus, stomach and duodenum, with prolonged exposure to gastric acid thought to be the primary cause.2,3 Risk factors include stress, intense exercise, a high-grain diet, intermittent feeding and illness.2,3 EGUS can have a profound impact on a horse's condition and performance and can ultimately be life threatening, especially in foals.3,5 It is a challenging condition to diagnose as the clinical signs are often vague and not always present.3 Gastroscopy is the only method currently available for a definitive diagnosis and treatment is usually based on acid suppressive therapy to allow ulcer healing.2
UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.1 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.1,2 One syringe contains enough UlcerGold for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Zoetis says UlcerGold is supported by a comprehensive gastroscope training programme, pricing model, client support and communications plan to ensure that it is a strong asset to veterinary businesses.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "UlcerGold is an exciting addition to our equine POM-V portfolio. We have designed a training, education and business programme to help practices make sure they get the best from our new product, not only in terms of gastric ulceration treatment but also practice health."
The RCVS has published its 2014 Survey of the Veterinary and Veterinary Nursing Professions, a snapshot of the demographics of the profession, and the educational and work status of its members.
The results, which gauge individual views on the current state of the profession, are used to inform the College's future policy and activities.
6,988 veterinary surgeons (27% of the profession), 3,612 registered/listed veterinary nurses (31% of the profession) and 1,792 student veterinary nurses took part in the surveys, which are conducted once every four years by the Institute for Employment Studies.
This year's surveys included a set of questions about 24-hour emergency cover, which contributed to the recent review of the College's guidance in this area, and, for the first time, questions from the government-backed Social Mobility Toolkit, which aim to assess the social background of members of the profession.
Highlights from the survey of veterinary surgeons included:
Highlights from the survey of veterinary nurses included:
Both the Survey of the Veterinary Profession and the Survey of the Veterinary Nursing Profession, together with a report that brings together common themes, can be downloaded from the RCVS publications page.